Integrating China in the International Consortium for Personalised Medicine (IC2PerMed)
Thanks to advances in biomedical and digital technologies, Personalised Medicine (PM) improves healthcare and underpin more efficient and sustainable health systems. In China it is attracting massive interest, with the government capitalising on its expertise in biotechnology, computing hardware and producing infrastructures for supporting bioinformatics projects. Turning PM into an opportunity for citizens and patients requires the engagement of stakeholders internationally to define common research and development approaches, standards and priorities. In order to respond to these challenges, the EU supports actions developed within the International Consortium for Personalised Medicine (ICPerMed). The EU-funded IC2PerMed project will provide key solutions for enabling the convergence under ICPerMed of European and Chinese stakeholders towards a common approach of PM, involving policymakers and healthcare beneficiaries.
Call for proposal
See other projects for this call
Funding SchemeCSA - Coordination and support action
92130 Issy Les Moulineaux